Measuring the sensitivity of COVID tests with new material from NIST

Researchers at the National Institute of Standards and Technology (NIST) have produced synthetic gene fragments from SARS-CoV-2, the virus that causes COVID-19. This material, which is non-infectious and safe to handle, can help manufacturers produce more accurate and reliable diagnostic tests for the disease. Tests for an active infection — as opposed to antibody tests…

Details

Sleep and diabetes study receives $3M grant

Getting more sleep and establishing a regular sleep schedule is a common recommendation for maintaining and improving health, including for people with Type 1 diabetes. Short sleep patterns may affect how the body uses insulin, and irregular sleep schedules can affect glucose through changes in one’s circadian rhythm or biological clock. But, how best to…

Details

Virtual imaging trials optimize CT, radiography for coronavirus disease (COVID-19)

Leesburg, VA, August 25, 2020—An open-access article in ARRS’ American Journal of Roentgenology (AJR) established a foundation for the use of virtual imaging trials in effective assessment and optimization of CT and radiography acquisitions and analysis tools to help manage the coronavirus disease (COVID-19) pandemic. Virtual imaging trials have two main components—representative models of targeted…

Details

A multicenter look at gene therapy for spinal muscular atrophy

In May 2019, the U.S. Food and Drug Administration (FDA) approved a gene replacement therapy for the inherited, progressive neuromuscular disease 5q-linked spinal muscular atrophy (SMA). Approval included all children with SMA under the age of two years; however, the gene therapy had only been studied in children aged up to 8 months. Now, a…

Details

F.D.A. ‘Grossly Misrepresented’ Blood Plasma Data, Scientists Say

At a news conference on Sunday announcing the emergency approval of blood plasma for hospitalized Covid-19 patients, President Trump and two of his top health officials cited the same statistic: that the treatment had reduced deaths by 35 percent. Mr. Trump called it a “tremendous” number. His health and human services secretary, Alex M. Azar…

Details

Trump Keeps Promoting a Drug Order That No One Has Seen

WASHINGTON — President Trump has made his executive order tying prescription drug prices in the United States to the prices paid in Europe and other developed nations — and the ensuing war that has broken out with the pharmaceutical industry — a centerpiece of his campaign for re-election. The problem: No such executive order has…

Details

Covid-19: Live News and Updates

Here’s what you need to know: A judge struck down a state order requiring most Florida schools to open for in-person instruction. ImageKatie Stallings, a second grade teacher, set up her classroom before her students return to school at MacFarlane Park IB Elementary, last week in Tampa, Fla.Credit…Octavio Jones for The New York Times A…

Details